Highbridge Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-2,300
Closed -$422K 481
2018
Q2
$422K Buy
+2,300
New +$407K 0.01% 624
2018
Q1
Sell
-1,300
Closed -$227K 1158
2017
Q4
$227K Sell
1,300
-3,000
-70% -$531K ﹤0.01% 1417
2017
Q3
$805K Buy
+4,300
New +$762K 0.01% 690
2017
Q2
Sell
-11,500
Closed -$1.89M 1216
2017
Q1
$1.89M Buy
11,500
+2,200
+24% +$366K 0.03% 460
2016
Q4
$1.36M Buy
9,300
+6,500
+232% +$978K 0.02% 466
2016
Q3
$465K Buy
+2,800
New +$473K 0.01% 813
2016
Q1
Sell
-4,800
Closed -$779K 1452
2015
Q4
$779K Buy
+4,800
New +$754K 0.01% 844
2015
Q3
Sell
-12,500
Closed -$1.92M 1503
2015
Q2
$1.92M Sell
12,500
-54,200
-81% -$8.68M 0.02% 533
2015
Q1
$10.7M Buy
66,700
+16,000
+32% +$2.52M 0.15% 187
2014
Q4
$8.07M Buy
50,700
+38,900
+330% +$6.06M 0.1% 241
2014
Q3
$1.66M Buy
11,800
+8,300
+237% +$1.08M 0.02% 529
2014
Q2
$414K Sell
3,500
-8,100
-70% -$938K 0.01% 783
2014
Q1
$1.43M Sell
11,600
-13,800
-54% -$1.67M 0.02% 475
2013
Q4
$2.9M Sell
25,400
-24,400
-49% -$2.78M 0.03% 343
2013
Q3
$5.57M Sell
49,800
-16,800
-25% -$1.82M 0.06% 317
2013
Q2
$6.57M Buy
+66,600
New +$6.91M 0.07% 279

Other funds holding AMGN

Highbridge Capital Management's AMGN Position: Q2 2018 in Review

Highbridge Capital Management sold out of Amgen (AMGN) in Q2 2018, closing a stake of 55,642 shares — an estimated $9.84M sold.

Highbridge Capital Management first reported a position in AMGN in Q2 2013 and held it in 16 quarters. The position peaked at $43.2M in Q3 2013. 1,763 funds tracked by Wall St. Rank hold AMGN as of Q2 2018.

  • Highbridge Capital Management reported no remaining Amgen position as of Q2 2018 after selling out during the quarter.
  • Highbridge Capital Management sold 55,642 Amgen shares in Q2 2018, an estimated $9.84M.
  • Highbridge Capital Management first reported a position in Amgen in Q2 2013 and held it in 16 quarters.
  • Highbridge Capital Management's Amgen position peaked at $43.2M in Q3 2013.
  • 1,763 funds tracked by Wall St. Rank held Amgen as of Q2 2018.

Based on Highbridge Capital Management's 13F filing for Q2 2018, filed 14 Aug 2018.